• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.00% Nasdaq Up0.38%

    Peregrine Pharmaceuticals, Inc. (PPHM)

    -NasdaqCM
    1.33 May 21, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingJan 31, 2015Oct 31, 2014Jul 31, 2014Apr 30, 2014
    Total Revenue 5,677   6,300   5,496   6,474  
    Cost of Revenue3,113  4,139  3,583  3,829  
    Gross Profit 2,564   2,161   1,913   2,645  
    Operating Expenses
    Research Development11,261  10,003  10,201  8,813  
    Selling General and Administrative4,325  4,295  4,883  4,361  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (13,022) (12,137) (13,171) (10,529)
    Income from Continuing Operations
    Total Other Income/Expenses Net29  37  42  281  
    Earnings Before Interest And Taxes(12,993)(12,100)(13,129)(10,248)
    Interest Expense1   -   -   -  
    Income Before Tax(12,994)(12,100)(13,129)(10,248)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(12,994)(12,100)(13,129)(10,248)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (12,994) (12,100) (13,129) (10,248)
    Preferred Stock And Other Adjustments(775)(774)(1,028)(401)
    Net Income Applicable To Common Shares (13,769) (12,874) (14,157) (10,649)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.